Clinical Trials Logo

Filter by:
NCT ID: NCT06375876 Not yet recruiting - Domestic Violence Clinical Trials

Single Session Intervention to Promote Hope

Start date: April 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a brief, self-guided single-session intervention (SSI) that targets the development of, or increase in, hope, and pilot test it for the primary outcomes of feasibility, acceptability/likeability, safety, and changes in hope, and the secondary outcomes of self-worth, empowerment, and emotional wellbeing among women experiencing intimate partner violence (IPV). The study will be conducted in 2 stages: intervention development (Intervention Development Stage), and pilot testing the intervention (Pilot Stage). The focus of this registration is the Pilot Stage.

NCT ID: NCT06375902 Not yet recruiting - Clinical trials for Schizophrenia; Psychosis

The Fragility of Metaphors (FraMe): Learning, Loosing, and How to Train Them

FRAME
Start date: April 2024
Phase:
Study type: Observational

Tracking down the difficulties in metaphor comprehension experienced by individuals with schizophrenia across different metaphor types and exploring the neurological correlates via EEG recording technique

NCT ID: NCT06376201 Not yet recruiting - Clinical trials for Invasive Fungal Disease

A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease

Start date: April 2024
Phase: Phase 4
Study type: Interventional

This study is a prospective, multicenter, single-arm study, that aims to evaluate the efficacy and safety of amphotericin B cholesterol-sulfate complex (ABCD) for injection in the first-line treatment of patients with invasive fungal diseases, hoping to provide a reference for the clinical treatment of invasive fungal diseases. Patients with hematologic diseases who meet the criteria for inclusion and discharge with febrile neutropenia and suspected fungal infection were treated with ABCD antifungal therapy for 14 days while receiving treatment for underlying diseases, and the response rate of treatment was observed.

NCT ID: NCT06376474 Not yet recruiting - Psoriasis Clinical Trials

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Start date: April 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study was to evaluate the pharmacokinetics of Hemay 005 tablets in subjects with mild, moderate liver impairment and normal liver function, and to provide a basis for the formulation of clinical medication regimens for patients with liver impairment.

NCT ID: NCT06377904 Not yet recruiting - Clinical trials for Patients Hospitalized in Geriatrics for Heart Failure

Clinical and Therapeutic Characteristics of Geriatric Patients Hospitalized for Heart Failure (AGING HF Study (AGe and Heart Failure IN Geriatrics))

AGING HF
Start date: April 2024
Phase:
Study type: Observational [Patient Registry]

This retrospective (between April 2020 and December 2023) then prospective (between January 2024 and August 2026), non-interventional cohort study has as its main objective to evaluate the clinical and therapeutic characteristics of patients aged 75 and over hospitalized in geriatrics for heart failure and also to evaluate the clinical characteristics and triggering factor(s) of acute heart failure.

NCT ID: NCT06379308 Not yet recruiting - Clinical trials for Anterior Cruciate Ligament Rupture

Anterior Cruciate Ligament (ACL) Revision Surgery: French National Study

Start date: April 2024
Phase:
Study type: Observational

This is a national multicentric study led by the French Arthroscopy Society (SFA) evaluating clinical practice in anterior cruciate ligament (ACL) revision surgery (epidemiological data, morphological data, operative data, clinical and functional outcomes, and surgical complication rates).

NCT ID: NCT06380153 Not yet recruiting - Psoriasis Clinical Trials

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment

Start date: April 2024
Phase: Phase 1
Study type: Interventional

The aim of this study was to evaluate the pharmacokinetics of Hemay005 tablets in subjects with mild to moderate renal impairment and normal renal function, and to provide a basis for the formulation of clinical medication regimens for patients with renal impairment.

NCT ID: NCT06380296 Not yet recruiting - Clinical trials for Pulp Disease, Dental

Outcomes of NeoMTA and NeoPUTTY Pulpotomies in Primary Molars

Start date: April 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the outcomes of different medications used for pulpotomies (baby root canal) in children. The main question it aims to answer is: • what are the long-term clinical and radiographic success of pulpotomies in baby teeth using two different medications (NeoMTA and NeoPUTTY) over a 24-month follow-up period? Healthy children aged between 3 and 10 years undergoing dental treatment under general anesthesia who have deep caries lesions approximating or reaching the nerve will be invited to participate in this study. Pulpotomies (baby root canal) will be performed by trained dentists following a protocol. Children will receive pulpotomies either with NeoMTA or NeoPUTTY, two medications indicated for the procedure. Participants will be asked to come for an appointment at 1, 6, 12 and 24 months after the procedure. Researcher will compare the clinical and radiographic performance of pulpotomies (baby root canal) done with both medications.

NCT ID: NCT06380725 Not yet recruiting - Dementia Clinical Trials

The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease

Start date: April 2024
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive dysfunction and behavioral impairment. It is currently the most common type of dementia in the old age. At present, the clinical treatment of Alzheimer's disease is expensive and has side effects, so it is very important to explore new methods of treatment for AD. Investigators designed a prospective, randomized, double-blinded and placebo-controlled trial to investigate the effect of transcranial alternating current stimulation (tACS) on cognitive function in AD patients and to assess the biological effectiveness of the treatment.

NCT ID: NCT06381258 Not yet recruiting - Clinical trials for Fetal Growth Retardation

Fetal Cardiac Function

Start date: April 2024
Phase:
Study type: Observational

The aim of our study is to evaluate the effect of PE and FGR on fetal cardiac function. Pregnancies with preeclampsia and FGR, and preeclampsia with normal fetal growth are evaluated by echocardiography and compared with uncomplicated pregnancies.